CLIA Kit for Insulin Like Growth Factor Binding Protein 7 (IGFBP7)

FSTL2; IGFBP-7v; MAC25; PSF; TAF; IGFBP-rP1; MAC25 protein; Prostacyclin-stimulating factor; PGI2-stimulating factor; Tumor-derived adhesion factor

  • CLIA Kit for Insulin Like Growth Factor Binding Protein 7 (IGFBP7) Packages (Simulation)
  • CLIA Kit for Insulin Like Growth Factor Binding Protein 7 (IGFBP7) Packages (Simulation)
  • CLIA Kit for Insulin Like Growth Factor Binding Protein 7 (IGFBP7) Results demonstration
  • SCB673Hu.jpg Typical Standard Curve
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the CLIA Kit for Insulin Like Growth Factor Binding Protein 7 (IGFBP7)

This assay has high sensitivity and excellent specificity for detection of Insulin Like Growth Factor Binding Protein 7 (IGFBP7).
No significant cross-reactivity or interference between Insulin Like Growth Factor Binding Protein 7 (IGFBP7) and analogues was observed.

Recovery of the CLIA Kit for Insulin Like Growth Factor Binding Protein 7 (IGFBP7)

Matrices listed below were spiked with certain level of recombinant Insulin Like Growth Factor Binding Protein 7 (IGFBP7) and the recovery rates were calculated by comparing the measured value to the expected amount of Insulin Like Growth Factor Binding Protein 7 (IGFBP7) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 79-94 88
EDTA plasma(n=5) 86-93 90
heparin plasma(n=5) 78-90 85

Precision of the CLIA Kit for Insulin Like Growth Factor Binding Protein 7 (IGFBP7)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Insulin Like Growth Factor Binding Protein 7 (IGFBP7) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Insulin Like Growth Factor Binding Protein 7 (IGFBP7) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity of the CLIA Kit for Insulin Like Growth Factor Binding Protein 7 (IGFBP7)

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Insulin Like Growth Factor Binding Protein 7 (IGFBP7) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 95-102% 87-101% 93-101% 94-105%
EDTA plasma(n=5) 84-101% 82-99% 83-101% 80-89%
heparin plasma(n=5) 89-104% 84-98% 82-96% 96-104%

Stability of the CLIA Kit for Insulin Like Growth Factor Binding Protein 7 (IGFBP7)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the CLIA Kit for Insulin Like Growth Factor Binding Protein 7 (IGFBP7)

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

Test principle of the CLIA Kit for Insulin Like Growth Factor Binding Protein 7 (IGFBP7)

The microplate provided in this kit has been pre-coated with an antibody specific to Insulin Like Growth Factor Binding Protein 7 (IGFBP7). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Insulin Like Growth Factor Binding Protein 7 (IGFBP7). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Insulin Like Growth Factor Binding Protein 7 (IGFBP7) level in the sample or standard.;

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPB673Hu01 Recombinant Insulin Like Growth Factor Binding Protein 7 (IGFBP7) Positive Control; Immunogen; SDS-PAGE; WB.
RPB673Hu03 Recombinant Insulin Like Growth Factor Binding Protein 7 (IGFBP7) Positive Control; Immunogen; SDS-PAGE; WB.
RPB673Hu02 Recombinant Insulin Like Growth Factor Binding Protein 7 (IGFBP7) Positive Control; Immunogen; SDS-PAGE; WB.
PAB673Hu01 Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 7 (IGFBP7) WB; IHC; ICC; IP.
MAB673Hu22 Monoclonal Antibody to Insulin Like Growth Factor Binding Protein 7 (IGFBP7) WB; IHC; ICC; IP.
SEB673Hu ELISA Kit for Insulin Like Growth Factor Binding Protein 7 (IGFBP7) Enzyme-linked immunosorbent assay for Antigen Detection.
SCB673Hu CLIA Kit for Insulin Like Growth Factor Binding Protein 7 (IGFBP7) Chemiluminescent immunoassay for Antigen Detection.
LMB673Hu Multiplex Assay Kit for Insulin Like Growth Factor Binding Protein 7 (IGFBP7) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
GUESTBOOK